Skip to main content
Top
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Keloid | Research

Identification of a potential bioinformatics-based biomarker in keloids and its correlation with immune infiltration

Authors: Zihan Li, Chuwei Zhang, Qingrong Zhang, Yipeng Dong, Xinyu Sha, Ming Jiang, Jun Yan, Wenmiao Wang, Houqiang Li, Yi Zhang, You Lang Zhou

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Keloid formation is a pathological consequence resulting from cutaneous irritation and injury, primarily attributed to excessive collagen matrix deposition and fibrous tissue proliferation. Chronic inflammation, left uncontrolled over an extended period, also stands as a substantial contributing factor. The precise mechanisms underlying keloid formation remain unclear. Therefore, this study aimed to identify key genes for diagnostic purposes. To achieve this, we used two Gene Expression Omnibus (GEO) data sets to identify differentially expressed genes. We identified one particular gene, homeobox C9 (HOXC9), using a thorough strategy involving two algorithms (least absolute shrinkage and selection operator and support vector machine-recursive feature elimination) and weighted gene co-expression network analysis. We then assessed its expression in normal and keloid tissues. In addition, we explored its temporal expression patterns via Mfuzz time clustering analysis. In our comprehensive analysis, we observed that immune infiltration, as well as cell proliferation, are crucial to keloid formation. Thus, we investigated immune cell infiltration in the keloid and normal groups, as well as the correlation between HOXC9 and these immune cells. It was found that HOXC9 was closely associated with the immune microenvironment of keloids. This shows that HOXC9 can serve as a potential biomarker and therapeutic target for keloids.
Literature
1.
go back to reference Ud-Din S, Bayat A. New insights on keloids, hypertrophic scars, and striae. Dermatol Clin. 2014;32(2):193–209.PubMedCrossRef Ud-Din S, Bayat A. New insights on keloids, hypertrophic scars, and striae. Dermatol Clin. 2014;32(2):193–209.PubMedCrossRef
2.
go back to reference Mustoe TA, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110(2):560–71.PubMedCrossRef Mustoe TA, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110(2):560–71.PubMedCrossRef
3.
go back to reference Ashcroft KJ, Syed F, Bayat A. Site-specific keloid fibroblasts alter the behaviour of normal skin and normal scar fibroblasts through paracrine signalling. PLoS ONE. 2013;8(12): e75600.PubMedPubMedCentralCrossRef Ashcroft KJ, Syed F, Bayat A. Site-specific keloid fibroblasts alter the behaviour of normal skin and normal scar fibroblasts through paracrine signalling. PLoS ONE. 2013;8(12): e75600.PubMedPubMedCentralCrossRef
4.
go back to reference Satish L, et al. Gene expression patterns in isolated keloid fibroblasts. Wound Repair Regen. 2006;14(4):463–70.PubMedCrossRef Satish L, et al. Gene expression patterns in isolated keloid fibroblasts. Wound Repair Regen. 2006;14(4):463–70.PubMedCrossRef
5.
go back to reference Verhaegen PD, et al. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: an objective histopathological analysis. Wound Repair Regen. 2009;17(5):649–56.PubMedCrossRef Verhaegen PD, et al. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: an objective histopathological analysis. Wound Repair Regen. 2009;17(5):649–56.PubMedCrossRef
6.
go back to reference Ud-Din S, Bayat A. Keloid scarring or disease: unresolved quasi-neoplastic tendencies in the human skin. Wound Repair Regen. 2020;28(3):422–6.PubMedCrossRef Ud-Din S, Bayat A. Keloid scarring or disease: unresolved quasi-neoplastic tendencies in the human skin. Wound Repair Regen. 2020;28(3):422–6.PubMedCrossRef
7.
go back to reference Tan S, Khumalo N, Bayat A. Understanding keloid pathobiology from a quasi-neoplastic perspective: less of a scar and more of a chronic inflammatory disease with cancer-like tendencies. Front Immunol. 2019;10:1810.PubMedPubMedCentralCrossRef Tan S, Khumalo N, Bayat A. Understanding keloid pathobiology from a quasi-neoplastic perspective: less of a scar and more of a chronic inflammatory disease with cancer-like tendencies. Front Immunol. 2019;10:1810.PubMedPubMedCentralCrossRef
8.
go back to reference Shaker SA, Ayuob NN, Hajrah NH. Cell talk: a phenomenon observed in the keloid scar by immunohistochemical study. Appl Immunohistochem Mol Morphol. 2011;19(2):153–9.PubMedCrossRef Shaker SA, Ayuob NN, Hajrah NH. Cell talk: a phenomenon observed in the keloid scar by immunohistochemical study. Appl Immunohistochem Mol Morphol. 2011;19(2):153–9.PubMedCrossRef
10.
go back to reference Song H, et al. Tension enhances cell proliferation and collagen synthesis by upregulating expressions of integrin alphavbeta3 in human keloid-derived mesenchymal stem cells. Life Sci. 2019;219:272–82.PubMedCrossRef Song H, et al. Tension enhances cell proliferation and collagen synthesis by upregulating expressions of integrin alphavbeta3 in human keloid-derived mesenchymal stem cells. Life Sci. 2019;219:272–82.PubMedCrossRef
11.
go back to reference Wolfram D, et al. Hypertrophic scars and keloids—a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg. 2009;35(2):171–81.PubMedCrossRef Wolfram D, et al. Hypertrophic scars and keloids—a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg. 2009;35(2):171–81.PubMedCrossRef
13.
14.
go back to reference Bayat A, et al. Keloid disease: clinical relevance of single versus multiple site scars. Br J Plast Surg. 2005;58(1):28–37.PubMedCrossRef Bayat A, et al. Keloid disease: clinical relevance of single versus multiple site scars. Br J Plast Surg. 2005;58(1):28–37.PubMedCrossRef
15.
go back to reference Buccitelli C, Selbach M. mRNAs, proteins and the emerging principles of gene expression control. Nat Rev Genet. 2020;21(10):630–44.PubMedCrossRef Buccitelli C, Selbach M. mRNAs, proteins and the emerging principles of gene expression control. Nat Rev Genet. 2020;21(10):630–44.PubMedCrossRef
16.
go back to reference de Sousa Abreu R, et al. Global signatures of protein and mRNA expression levels. Mol Biosyst. 2009;5(12):1512–26.PubMed de Sousa Abreu R, et al. Global signatures of protein and mRNA expression levels. Mol Biosyst. 2009;5(12):1512–26.PubMed
17.
go back to reference Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597–610.PubMedCrossRef Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597–610.PubMedCrossRef
18.
go back to reference Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559.CrossRef Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559.CrossRef
20.
go back to reference Smith JC, et al. Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol. 2008;128(5):1298–310.PubMedCrossRef Smith JC, et al. Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol. 2008;128(5):1298–310.PubMedCrossRef
21.
22.
go back to reference Kang Y, et al. Hypoxia and HIF-1α regulate collagen production in keloids. J Invest Dermatol. 2020;140(11):2157–65.PubMedCrossRef Kang Y, et al. Hypoxia and HIF-1α regulate collagen production in keloids. J Invest Dermatol. 2020;140(11):2157–65.PubMedCrossRef
24.
go back to reference Troiano M, et al. Giant keloid of left buttock treated with post-excisional radiotherapy. J Radiol Case Rep. 2011;5(9):8–15.PubMedPubMedCentral Troiano M, et al. Giant keloid of left buttock treated with post-excisional radiotherapy. J Radiol Case Rep. 2011;5(9):8–15.PubMedPubMedCentral
25.
go back to reference Syed F, Bayat A. Notch signaling pathway in keloid disease: enhanced fibroblast activity in a Jagged-1 peptide-dependent manner in lesional vs extralesional fibroblasts. Wound Repair Regen. 2012;20(5):688–706.PubMedCrossRef Syed F, Bayat A. Notch signaling pathway in keloid disease: enhanced fibroblast activity in a Jagged-1 peptide-dependent manner in lesional vs extralesional fibroblasts. Wound Repair Regen. 2012;20(5):688–706.PubMedCrossRef
26.
go back to reference Syed F, et al. Keloid disease can be inhibited by antagonizing excessive mTOR signaling with a novel dual TORC1/2 inhibitor. Am J Pathol. 2012;181(5):1642–58.PubMedCrossRef Syed F, et al. Keloid disease can be inhibited by antagonizing excessive mTOR signaling with a novel dual TORC1/2 inhibitor. Am J Pathol. 2012;181(5):1642–58.PubMedCrossRef
27.
go back to reference Friedman DW, et al. Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res. 1993;55(2):214–22.PubMedCrossRef Friedman DW, et al. Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res. 1993;55(2):214–22.PubMedCrossRef
28.
go back to reference Lee JY, et al. Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol. 2004;26(5):379–84.PubMedCrossRef Lee JY, et al. Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol. 2004;26(5):379–84.PubMedCrossRef
29.
go back to reference Babu M, Diegelmann R, Oliver N. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol. 1989;9(4):1642–50.PubMedPubMedCentral Babu M, Diegelmann R, Oliver N. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol. 1989;9(4):1642–50.PubMedPubMedCentral
30.
go back to reference da Silva IR, et al. In situ cytokine expression and morphometric evaluation of total collagen and collagens Type I and Type III in keloid scars. Mediators Inflamm. 2017;2017:6573802.PubMedPubMedCentralCrossRef da Silva IR, et al. In situ cytokine expression and morphometric evaluation of total collagen and collagens Type I and Type III in keloid scars. Mediators Inflamm. 2017;2017:6573802.PubMedPubMedCentralCrossRef
32.
go back to reference Stoll SJ, Kroll J. HOXC9: a key regulator of endothelial cell quiescence and vascular morphogenesis. Trends Cardiovasc Med. 2012;22(1):7–11.PubMedCrossRef Stoll SJ, Kroll J. HOXC9: a key regulator of endothelial cell quiescence and vascular morphogenesis. Trends Cardiovasc Med. 2012;22(1):7–11.PubMedCrossRef
33.
go back to reference Stoll SJ, et al. The transcription factor HOXC9 regulates endothelial cell quiescence and vascular morphogenesis in zebrafish via inhibition of interleukin 8. Circ Res. 2011;108(11):1367–77.PubMedCrossRef Stoll SJ, et al. The transcription factor HOXC9 regulates endothelial cell quiescence and vascular morphogenesis in zebrafish via inhibition of interleukin 8. Circ Res. 2011;108(11):1367–77.PubMedCrossRef
34.
35.
go back to reference Zhao XF, Yang YS, Park YK. HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients. Int J Clin Oncol. 2020;25(12):2044–54.PubMedCrossRef Zhao XF, Yang YS, Park YK. HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients. Int J Clin Oncol. 2020;25(12):2044–54.PubMedCrossRef
36.
go back to reference Liu Y, Jing L, Zhang J. circRNA-mediated upregulation of HOXC9 is correlated with poor outcome and immune microenvironment infiltrates in LUAD. Biochem Biophys Res Commun. 2022;635:128–35.PubMedCrossRef Liu Y, Jing L, Zhang J. circRNA-mediated upregulation of HOXC9 is correlated with poor outcome and immune microenvironment infiltrates in LUAD. Biochem Biophys Res Commun. 2022;635:128–35.PubMedCrossRef
37.
go back to reference Peng X, et al. miR-26a/HOXC9 dysregulation promotes metastasis and stem cell-like phenotype of gastric cancer. Cell Physiol Biochem. 2018;49(4):1659–76.PubMedCrossRef Peng X, et al. miR-26a/HOXC9 dysregulation promotes metastasis and stem cell-like phenotype of gastric cancer. Cell Physiol Biochem. 2018;49(4):1659–76.PubMedCrossRef
38.
go back to reference Tang Y, et al. Upregulation of HOXC9 generates interferon-gamma resistance in gastric cancer by inhibiting the DAPK1/RIG1/STAT1 axis. Cancer Sci. 2021;112(9):3455–68.PubMedPubMedCentralCrossRef Tang Y, et al. Upregulation of HOXC9 generates interferon-gamma resistance in gastric cancer by inhibiting the DAPK1/RIG1/STAT1 axis. Cancer Sci. 2021;112(9):3455–68.PubMedPubMedCentralCrossRef
40.
go back to reference Ye C, et al. MDM2 mediates fibroblast activation and renal tubulointerstitial fibrosis via a p53-independent pathway. Am J Physiol Renal Physiol. 2017;312(4):F760–8.PubMedCrossRef Ye C, et al. MDM2 mediates fibroblast activation and renal tubulointerstitial fibrosis via a p53-independent pathway. Am J Physiol Renal Physiol. 2017;312(4):F760–8.PubMedCrossRef
43.
go back to reference Zou Y, et al. LncRNA THRIL is involved in the proliferation, migration, and invasion of rheumatoid fibroblast-like synoviocytes. Ann Transl Med. 2021;9(17):1368.PubMedPubMedCentralCrossRef Zou Y, et al. LncRNA THRIL is involved in the proliferation, migration, and invasion of rheumatoid fibroblast-like synoviocytes. Ann Transl Med. 2021;9(17):1368.PubMedPubMedCentralCrossRef
45.
go back to reference Fadaka AO, et al. Expression of cyclin-dependent kinases and their clinical significance with immune infiltrates could predict prognosis in colorectal cancer. Biotechnol Rep (Amst). 2021;29: e00602.PubMedCrossRef Fadaka AO, et al. Expression of cyclin-dependent kinases and their clinical significance with immune infiltrates could predict prognosis in colorectal cancer. Biotechnol Rep (Amst). 2021;29: e00602.PubMedCrossRef
46.
go back to reference Zou Y, et al. CDK1, CCNB1, and CCNB2 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma. Med Sci Monit. 2020;26: e925289.PubMedPubMedCentralCrossRef Zou Y, et al. CDK1, CCNB1, and CCNB2 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma. Med Sci Monit. 2020;26: e925289.PubMedPubMedCentralCrossRef
47.
go back to reference Chen X, et al. Identification of aging-related genes associated with clinical and prognostic features of hepatocellular carcinoma. Front Genet. 2021;12: 661988.PubMedPubMedCentralCrossRef Chen X, et al. Identification of aging-related genes associated with clinical and prognostic features of hepatocellular carcinoma. Front Genet. 2021;12: 661988.PubMedPubMedCentralCrossRef
49.
go back to reference Trace AP, et al. Keloids and hypertrophic scars: a spectrum of clinical challenges. Am J Clin Dermatol. 2016;17(3):201–23.PubMedCrossRef Trace AP, et al. Keloids and hypertrophic scars: a spectrum of clinical challenges. Am J Clin Dermatol. 2016;17(3):201–23.PubMedCrossRef
50.
go back to reference Harrop AR, et al. Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-gamma. J Surg Res. 1995;58(5):471–7.PubMedCrossRef Harrop AR, et al. Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-gamma. J Surg Res. 1995;58(5):471–7.PubMedCrossRef
51.
go back to reference Bagabir R, et al. Site-specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates. Br J Dermatol. 2012;167(5):1053–66.PubMedCrossRef Bagabir R, et al. Site-specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates. Br J Dermatol. 2012;167(5):1053–66.PubMedCrossRef
52.
go back to reference Komi DEA, Khomtchouk K, Santa Maria PL. A review of the contribution of mast cells in wound healing: involved molecular and cellular mechanisms. Clin Rev Allergy Immunol. 2020;58(3):298–312.PubMedCrossRef Komi DEA, Khomtchouk K, Santa Maria PL. A review of the contribution of mast cells in wound healing: involved molecular and cellular mechanisms. Clin Rev Allergy Immunol. 2020;58(3):298–312.PubMedCrossRef
53.
go back to reference Zhang Q, et al. Green tea extract and (-)-epigallocatechin-3-gallate inhibit mast cell-stimulated type I collagen expression in keloid fibroblasts via blocking PI-3K/AkT signaling pathways. J Invest Dermatol. 2006;126(12):2607–13.PubMedCrossRef Zhang Q, et al. Green tea extract and (-)-epigallocatechin-3-gallate inhibit mast cell-stimulated type I collagen expression in keloid fibroblasts via blocking PI-3K/AkT signaling pathways. J Invest Dermatol. 2006;126(12):2607–13.PubMedCrossRef
54.
go back to reference Luk K, Fakhoury J, Ozog D. Nonresponse and progression of diffuse keloids to dupilumab therapy. J Drugs Dermatol. 2022;21(2):197–9.PubMedCrossRef Luk K, Fakhoury J, Ozog D. Nonresponse and progression of diffuse keloids to dupilumab therapy. J Drugs Dermatol. 2022;21(2):197–9.PubMedCrossRef
55.
go back to reference Lee SY, et al. IL-17 induced stromal cell-derived factor-1 and profibrotic factor in keloid-derived skin fibroblasts via the STAT3 pathway. Inflammation. 2020;43(2):664–72.PubMedCrossRef Lee SY, et al. IL-17 induced stromal cell-derived factor-1 and profibrotic factor in keloid-derived skin fibroblasts via the STAT3 pathway. Inflammation. 2020;43(2):664–72.PubMedCrossRef
56.
go back to reference Lee SY, et al. IL-17 induces autophagy dysfunction to promote inflammatory cell death and fibrosis in keloid fibroblasts via the STAT3 and HIF-1alpha dependent signaling pathways. Front Immunol. 2022;13: 888719.PubMedPubMedCentralCrossRef Lee SY, et al. IL-17 induces autophagy dysfunction to promote inflammatory cell death and fibrosis in keloid fibroblasts via the STAT3 and HIF-1alpha dependent signaling pathways. Front Immunol. 2022;13: 888719.PubMedPubMedCentralCrossRef
57.
go back to reference Chen Z, et al. Characterization of CD45RO(+) memory T lymphocytes in keloid disease. Br J Dermatol. 2018;178(4):940–50.PubMedCrossRef Chen Z, et al. Characterization of CD45RO(+) memory T lymphocytes in keloid disease. Br J Dermatol. 2018;178(4):940–50.PubMedCrossRef
58.
go back to reference Xu J, et al. Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma. Arch Dermatol Res. 2020;312(7):513–25.PubMedCrossRef Xu J, et al. Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma. Arch Dermatol Res. 2020;312(7):513–25.PubMedCrossRef
Metadata
Title
Identification of a potential bioinformatics-based biomarker in keloids and its correlation with immune infiltration
Authors
Zihan Li
Chuwei Zhang
Qingrong Zhang
Yipeng Dong
Xinyu Sha
Ming Jiang
Jun Yan
Wenmiao Wang
Houqiang Li
Yi Zhang
You Lang Zhou
Publication date
01-12-2023
Publisher
BioMed Central
Keywords
Keloid
Biomarkers
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01421-y

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue